HIV and SARS-Cov-2 Co-Infection: A Local Perspective
Yıl: 2022 Cilt: 4 Sayı: 2 Sayfa Aralığı: 122 - 128 Metin Dili: İngilizce DOI: 10.36519/idcm.2022.131 İndeks Tarihi: 19-07-2022
HIV and SARS-Cov-2 Co-Infection: A Local Perspective
Öz: Objective: As the Coronavirus disease 2019 (COVID-19) pandemic spread globally, more
human immunodeficiency virus (HIV) positive patients began to appear infected with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We aimed to evaluate the
clinical course of HIV and SARS-CoV-2 co-infected patients from a local perspective.
Methods: HIV and SARS-CoV-2 co-infected patients diagnosed between March 2020 to June
2021 at a tertiary hospital in Turkey were analyzed retrospectively.
Results: Thirty HIV and SARS-CoV-2 co-infected patients were included. Five patients
were female, 25 were male, and the mean age was 44.5 ±10.2 years. Twenty-three (76.7%)
patients were known to be HIV-positive before their admission to the hospital, and seven
(23.7%) patients, were detected by screening after the diagnosis of COVID-19. All patients
were known to be HIV-positive; they were on antiretroviral therapy (ART) and virologically
suppressed. Twenty-seven patients had a mild course. Three patients were hospitalized, and
of them, two patients had died. All hospitalized patients were male and were ART-naïve.
Conclusion: HIV infection alone did not increase the severity of the course of COVID-19 and
did not increase the mortality in COVID-19.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1 Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-1207. [CrossRef]
- 2 COVID-19 Dashboard [Internet]. Johns Hopkins University of Medicine Coronavirus Resource Center. (cited February 23, 2022). Available from: https://coronavirus.jhu.edu/map.html
- 3 [COVID-19 Information Platform] [Internet]. Ankara: Republic of Türkiye Ministry of Health. (cited February 23, 2022). Turkish. Available from: https://covid19.saglik.gov.tr
- 4 HIV/ AIDS [Internet]. Geneva: World Health Organisation, The Global Health Observatory. (cited February 23, 2022). Available from: https://www.who.int/data/gho/data/themes/hiv-aids
- 5 [HIV-AIDS Statistics] [Internet]. Ankara: Republic of Türkiye Ministry of Health, General Directorate of Public Health. (cited February 23, 2022). Available from: https://hsgm.saglik.gov.tr/ tr/bulasici-hastaliklar/hiv-aids/hiv-aids-liste/hiv-aids-istatislik. html
- 6 Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015;26:26191. [CrossRef]
- 7 Borges ÁH, O’Connor JL, Phillips AN, Neaton JD, Grund B, Neuhaus J, et al. Interleukin 6 is a stronger predictor of clinical events than high-sensitivity C-reactive protein or D-dimer during HIV infection. J Infect Dis. 2016;214(3):408-16. [Cross- Ref]
- 8 Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERSCoV, and 2019-nCoV. J Med Virol. 2020;92(5):491-4. [CrossRef]
- 9 Tartof SY, Qian L, Hong V, Wei R, Nadjafi RF, Fischer H, et al. Obesity and mortality among patients diagnosed with COVID-19: Results from an integrated health care organization. Ann Intern Med. 2020;173:773-81. [CrossRef]
- 10 Anderson MR, Geleris J, Anderson DR, Zucker J, Nobel YR, Freedberg D, et al. Body mass index and risk for intubation or death in SARS-CoV-2 infection: a retrospective cohort study. Ann Intern Med. 2020;173(10):782-90. [CrossRef]
- 11 Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. Erratum in: Lancet Respir Med. 2020;8(6):e54. [CrossRef]
- 12 Clinical spectrum of SARS-CoV-2 infection [Internet]. New York: National Institutes of Health. (updated October 19, 2021; cited February 23, 2022). Available from: https://www. covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/
- 13 Body mass index - BMI [Internet]. Geneva: World Health Organisation. (cited February 23, 2022). Available from: https:// www.euro.who.int/en/health-topics/disease-prevention/nutrition/ a-healthy-lifestyle/body-mass-index-bmi
- 14 Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–8. [CrossRef]
- 15 Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9. [CrossRef]
- 16 Gatechompol S, Avihingsanon A, Putcharoen O, Ruxrungtham K, Kuritzkes DR. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature. AIDS Res Ther. 2021;18(1):28. [CrossRef]
- 17 Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, et al. HIV infection and COVID-19 death: a population- based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021;8(1):e24-e32. [CrossRef]
- 18 Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep. 2021;11(1):6283. [CrossRef]
- 19 Tesoriero JM, Swain CE, Pierce JL, Zamboni L, Wu M, Holtgrave DR, et al. COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State. JAMA Netw Open. 2021;4(2):e2037069. [CrossRef]
- 20 Liu Y, Xiao Y, Wu S, Marly G, Ming F, Wang X, et al. People Living with HIV Easily lose their Immune Response to SARS-CoV-2: Result from A Cohort of COVID-19 Cases in Wuhan, China. Res Sq [Preprint]. 2021:rs.3.rs-543375. [CrossRef]
- 21 Eybpoosh S, Afshari M, Haghdoost AA, Afsar Kazerooni P, Gouya MM, Tayeri K. Severity and mortality of COVID-19 infection in HIV-infected individuals: Preliminary findings from Iran. Med J Islam Repub Iran. 2021;35:33. [CrossRef]
- 22 Karmen-Tuohy S, Carlucci PM, Zervou FN, Zacharioudakis IM, Rebick G, Klein E, et al. Outcomes among HIV-positive patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2020;85(1):6-10. [CrossRef]
- 23 Härter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, et al. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection. 2020;48(5):681-6. [CrossRef]
- 24 Elfiky AA. Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci. 2020;253:117592. [CrossRef]
- 25 Park SY, Lee JS, Son JS, Ko JH, Peck KR, Jung Y, et al. Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers. J Hosp Infect. 2019;101(1):42-6. [CrossRef]
- 26 Vizcarra P, Pérez-Elías MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020;7(8):e554–64. [CrossRef]
- 27 Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382(19):1787-99. [CrossRef]
- 28 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62. [CrossRef]
- 29 Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. [CrossRef]
- 30 Altuntas-Aydin O, Kumbasar-Karaosmanoglu H, Kart-Yasar K. HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey. J Med Virol. 2020;92(11):2288-90. [CrossRef]
| APA | Bilek H, Deveci A (2022). HIV and SARS-Cov-2 Co-Infection: A Local Perspective. , 122 - 128. 10.36519/idcm.2022.131 |
| Chicago | Bilek Heval Can,Deveci Aydın HIV and SARS-Cov-2 Co-Infection: A Local Perspective. (2022): 122 - 128. 10.36519/idcm.2022.131 |
| MLA | Bilek Heval Can,Deveci Aydın HIV and SARS-Cov-2 Co-Infection: A Local Perspective. , 2022, ss.122 - 128. 10.36519/idcm.2022.131 |
| AMA | Bilek H,Deveci A HIV and SARS-Cov-2 Co-Infection: A Local Perspective. . 2022; 122 - 128. 10.36519/idcm.2022.131 |
| Vancouver | Bilek H,Deveci A HIV and SARS-Cov-2 Co-Infection: A Local Perspective. . 2022; 122 - 128. 10.36519/idcm.2022.131 |
| IEEE | Bilek H,Deveci A "HIV and SARS-Cov-2 Co-Infection: A Local Perspective." , ss.122 - 128, 2022. 10.36519/idcm.2022.131 |
| ISNAD | Bilek, Heval Can - Deveci, Aydın. "HIV and SARS-Cov-2 Co-Infection: A Local Perspective". (2022), 122-128. https://doi.org/10.36519/idcm.2022.131 |
| APA | Bilek H, Deveci A (2022). HIV and SARS-Cov-2 Co-Infection: A Local Perspective. Infectious diseases and clinical microbiology (Online), 4(2), 122 - 128. 10.36519/idcm.2022.131 |
| Chicago | Bilek Heval Can,Deveci Aydın HIV and SARS-Cov-2 Co-Infection: A Local Perspective. Infectious diseases and clinical microbiology (Online) 4, no.2 (2022): 122 - 128. 10.36519/idcm.2022.131 |
| MLA | Bilek Heval Can,Deveci Aydın HIV and SARS-Cov-2 Co-Infection: A Local Perspective. Infectious diseases and clinical microbiology (Online), vol.4, no.2, 2022, ss.122 - 128. 10.36519/idcm.2022.131 |
| AMA | Bilek H,Deveci A HIV and SARS-Cov-2 Co-Infection: A Local Perspective. Infectious diseases and clinical microbiology (Online). 2022; 4(2): 122 - 128. 10.36519/idcm.2022.131 |
| Vancouver | Bilek H,Deveci A HIV and SARS-Cov-2 Co-Infection: A Local Perspective. Infectious diseases and clinical microbiology (Online). 2022; 4(2): 122 - 128. 10.36519/idcm.2022.131 |
| IEEE | Bilek H,Deveci A "HIV and SARS-Cov-2 Co-Infection: A Local Perspective." Infectious diseases and clinical microbiology (Online), 4, ss.122 - 128, 2022. 10.36519/idcm.2022.131 |
| ISNAD | Bilek, Heval Can - Deveci, Aydın. "HIV and SARS-Cov-2 Co-Infection: A Local Perspective". Infectious diseases and clinical microbiology (Online) 4/2 (2022), 122-128. https://doi.org/10.36519/idcm.2022.131 |
